From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
Cancers | Targeted gene products†| References |
---|---|---|
Cancers with down-regulation of miR-375-3p | ||
 | Acting as oncogenes or tumor promoters | |
CRC | TYMS, CBX3, FOXM1, | Xu et al. (2020b);Â Liu et al. (2020a); Chen et al. (2020b); |
 | FZD8, PIK3CA, YAP1 | |
ESCC | MTDH | Hu et al. (2017b) |
GC | PDPK1, TEAD4, YAP1, | |
 | YBX1, YWHAZ | |
OSCC | SLC7A11 | Wu et al. (2017) |
NSCLC | SPIN1 | Jin et al. (2021) |
HCC | ERBB2, HMGA2, JAK2 | |
HCC | MTDH, PDGFC, YAP1 | |
HCC CSCs | YAP1 | Zhao et al. (2020a) |
PDAC | PDPK1, ZFP36L2 | Zhou et al. (2014b);Â Song et al. (2013a);Â Yonemori et al. (2017) |
OVCA | YAP1 | Shu et al. (2021) |
 | Acting both as oncogenes and tumor suppressors, or unclassified | |
CRC | KLF4, SP1 | |
GC | CCN2 | Kang et al. (2018) |
ESCC | HMGB1, IGF1R, SESN3, | Cheng et al. (2020b);Â Kong et al. (2012); Li et al. (2021a) |
 | SP1 | Xu et al. (2019b) |
LSCC | HNF1B, IGF1R | |
OSCC | KLF5, IGF1R, PAX6 | |
CeCa | SP1 | Wang et al. (2011) |
Cancers with up-regulation of miR-375-3p | ||
 | Acting as tumor suppressors | |
BRCA | FOXO1 | Guan et al. (2021) |
CeCa | CDH1 | Shen et al. (2014) |
 | Acting both as oncogenes and tumor suppressors, or unclassified | |
PDAC | HOXB3 | Yang et al. (2016) |